The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy

Human Genetics

Volumn 134, Issue 2, 2015, Pages 247-257

  Hosseini, S Mohsen ^a,b   Boright, Andrew P ^b,c   Sun, Lei ^d   Canty, Angelo J ^e   Bull, Shelley B ^d,f   Klein, Barbara E K ^g   Klein, Ronald ^g   Paterson, Andrew D ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LMC DIABETES AND ENDOCRINOLOGY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; CELL SURFACE RECEPTOR; EPO PROTEIN, HUMAN; ERYTHROPOIETIN; PLXDC2 PROTEIN, HUMAN;

ARTICLE; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DNA POLYMORPHISM; EYE PHOTOGRAPHY; FALSE POSITIVE RESULT; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; OPHTHALMOSCOPY; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STEREOSCOPIC VISION; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); FEMALE; GENETIC POLYMORPHISM; GENETICS; MALE; MULTICENTER STUDY;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ERYTHROPOIETIN; FEMALE; GENETIC LOCI; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE;

EID: 84925496830     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-014-1517-2     Document Type: Article

References (42)

1. Abhary S, Hewitt AW, Burdon KP, Craig JE (2009) A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 58:2137–2147. doi:10.2337/db09-0059
2. Abhary S, Burdon KP, Casson RJ, Goggin M, Petrovsky NP, Craig JE (2010) Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol 128:102–106. doi:10.1001/archophthalmol.2009.355
3. Atkins RC (2005) The epidemiology of chronic kidney disease. Kidney Int 67:S14–S18
4. Balasubbu S, Sundaresan P, Rajendran A, Ramasamy K, Govindarajan G, Perumalsamy N, Hejtmancik JF (2010) Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet 11:158. doi:10.1186/1471-2350-11-158
5. Brennan E, McEvoy C, Sadlier D, Godson C, Martin F (2013) The genetics of diabetic nephropathy. Genes 4:596–619
6. Centers for Disease Control and Prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
7. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS (2007) Replicating genotype–phenotype associations. Nature 447:655–660. doi:10.1038/447655a
8. Dudbridge F, Gusnanto A (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32:227–234. doi:10.1002/gepi.20297
9. Fisher RA (1932) Statistical methods for research workers, 4th edn. Oliver and Boyd, Edinburgh
10. Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clin Diabetes 26:77–82. doi:10.2337/diaclin.26.2.77
11. Fu YP, Hallman DM, Gonzalez VH, Klein BE, Klein R, Hayes MG, Cox NJ, Bell GI, Hanis CL (2010) Identification of diabetic retinopathy genes through a Genome-Wide Association Study among Mexican–Americans from Starr County, Texas. J Ophthalmol. doi: 10.1155/2010/861291
12. Garcia-Ramirez M, Hernandez C, Simo R (2008) Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care 31:1189–1194. doi:10.2337/dc07-2075
13. Grassi MA, Tikhomirov A, Ramalingam S, Below JE, Cox NJ, Nicolae DL (2011) Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 20:2472–2481. doi:10.1093/hmg/ddr121
14. Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S, Pearson JV, Lee AM, Knowler WC, Nelson RG, Wolford JK (2007) Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56:975–983. doi:10.2337/db06-1072
15. Howie BN, Donnelly P, Marchini J (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5:e1000529. doi:10.1371/journal.pgen.1000529
16. Hu C, Zhang R, Yu W, Wang J, Wang C, Pang C, Ma X, Bao Y, Xiang K, Jia W (2011) CPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients. Diabetes 60:3085–3089. doi:10.2337/db11-0028
17. Huang YC, Lin JM, Lin HJ, Chen CC, Chen SY, Tsai CH, Tsai FJ (2011) Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 118:642–648. doi:10.1016/j.ophtha.2010.07.020
18. Ioannidis JP, Thomas G, Daly MJ (2009) Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 10:318–329. doi:10.1038/nrg2544
19. Jensen RA, Sim X, Li X, Cotch MF, Ikram MK, Holliday EG, Eiriksdottir G, Harris TB, Jonasson F, Klein BE, Launer LJ, Smith AV, Boerwinkle E, Cheung N, Hewitt AW, Liew G, Mitchell P, Wang JJ, Attia J, Scott R, Glazer NL, Lumley T, McKnight B, Psaty BM, Taylor K, Hofman A, de Jong PT, Rivadeneira F, Uitterlinden AG, Tay WT, Teo YY, Seielstad M, Liu J, Cheng CY, Saw SM, Aung T, Ganesh SK, O’Donnell CJ, Nalls MA, Wiggins KL, Kuo JZ, van Duijn CM, Gudnason V, Klein R, Siscovick DS, Rotter JI, Tai ES, Vingerling J, Wong TY (2013) Genome-wide association study of retinopathy in individuals without diabetes. PLoS One 8:e54232. doi:10.1371/journal.pone.0054232
20. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE (2008) The Wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115:1859–1868. doi:10.1016/j.ophtha.2008.08.023
21. Li MX, Yeung JM, Cherny SS, Sham PC (2012) Evaluating the effective numbers of independent tests and significant p value thresholds in commercial genotyping arrays and public imputation reference datasets. Hum Genet 131:747–756. doi:10.1007/s00439-011-1118-2
22. Ma J, Li Y, Zhou F, Xu X, Guo G, Qu Y (2012) Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene and diabetic retinopathy in Caucasians and Asians. Mol Vis 18:2352–2360
23. Miller-Delaney SF, Lieberam I, Murphy P, Mitchell KJ (2011) Plxdc2 is a mitogen for neural progenitors. PLoS One 6:e14565. doi:10.1371/journal.pone.0014565
24. Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ (2011) Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 54:544–553. doi:10.1007/s00125-010-1996-1
25. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, Shen E, Mirea L, Bharaj B, Sun L, Bull SB (2009) Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 29:1958–1967. doi:10.1161/ATVBAHA.109.192971
26. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH, Bochenski J, Waggott D, Merchant ML, Krolewski B, Mirea L, Wanic K, Katavetin P, Kure M, Wolkow P, Dunn JS, Smiles A, Walker WH, Boright AP, Bull SB, Doria A, Rogus JJ, Rich SS, Warram JH, Krolewski AS (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58:1403–1410. doi:10.2337/db08-1514
27. Roy MS, Hallman DM, Fu YP, Machado M, Hanis CL (2009) Assessment of 193 candidate genes for retinopathy in African Americans with type 1 diabetes. Arch Ophthalmol 127:605–612. doi:10.1001/archophthalmol.2009.48
28. Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Makinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkila O, Hietala K, Kyto J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkaniemi J, Rosengard-Barlund M, Saraheimo M, Sarti C, Soderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Waden J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Mollsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP (2012) New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 8:e1002921. doi:10.1371/journal.pgen.1002921
29. Sheu WH, Kuo JZ, Lee IT, Hung YJ, Lee WJ, Tsai HY, Wang JS, Goodarzi MO, Klein R, Klein BE, Ipp E, Lin SY, Guo X, Hsieh CH, Taylor KD, Fu CP, Rotter JI, Chen YD (2013) Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet. doi:10.1093/hmg/ddt161
30. Sobrin L, Green T, Sim X, Jensen RA, Tai ES, Tay WT, Wang JJ, Mitchell P, Sandholm N, Liu Y, Hietala K, Iyengar SK, Brooks M, Buraczynska M, Van Zuydam N, Smith AV, Gudnason V, Doney AS, Morris AD, Leese GP, Palmer CN, Swaroop A, Taylor HA Jr, Wilson JG, Penman A, Chen CJ, Groop PH, Saw SM, Aung T, Klein BE, Rotter JI, Siscovick DS, Cotch MF, Klein R, Daly MJ, Wong TY (2011) Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci 52:7593–75602. doi:10.1167/iovs.11-7510
31. Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM (1949) The American soldier: adjustment during army life, vol I. Princeton University Press, Princeton
32. Sun L, Dimitromanolakis A, Faye LL, Paterson AD, Waggott D, Bull SB (2011) BR-squared: a practical solution to the winner’s curse in genome-wide scans. Hum Genet 129:545–552. doi:10.1007/s00439-011-0948-2
33. The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
34. The DCCT Research Group (1995) The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol 113:36–51
35. The DCCT Research Group (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829–1839
36. The International HapMap 3 Consortium (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467:452–458. doi:10.1038/nature09298
37. Tian C, Fang S, Du X, Jia C (2011) Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis. Diabetologia 54:803–811. doi:10.1007/s00125-010-2004-5
38. Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen Y, Yu B, Tinkham NH, Zabriskie NA, Zeng J, Luo L, Sun JK, Prakash M, Hamam RN, Tonna S, Constantine R, Ronquillo CC, Sadda S, Avery RL, Brand JM, London N, Anduze AL, King GL, Bernstein PS, Watkins S, Jorde LB, Li DY, Aiello LP, Pollak MR, Zhang K (2008) Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA 105:6998–7003. doi:10.1073/pnas.0800454105
39. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H (2005) Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353:782–792. doi:10.1056/NEJMoa041773
40. White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD (2010) Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 59:1244–1253. doi:10.2337/db09-1216
41. Williams WW, Salem RM, McKnight AJ, Sandholm N, Forsblom C, Taylor A, Guiducci C, McAteer JB, McKay GJ, Isakova T, Brennan EP, Sadlier DM, Palmer C, Soderlund J, Fagerholm E, Harjutsalo V, Lithovius R, Gordin D, Hietala K, Kyto J, Parkkonen M, Rosengard-Barlund M, Thorn L, Syreeni A, Tolonen N, Saraheimo M, Waden J, Pitkaniemi J, Sarti C, Tuomilehto J, Tryggvason K, Osterholm AM, He B, Bain S, Martin F, Godson C, Hirschhorn JN, Maxwell AP, Groop PH, Florez JC (2012) Association testing of previously reported variants in a large case–control meta-analysis of diabetic nephropathy. Diabetes 61:2187–2194. doi:10.2337/db11-0751
42. Yamaji Y, Yoshida S, Ishikawa K, Sengoku A, Sato K, Yoshida A, Kuwahara R, Ohuchida K, Oki E, Enaida H, Fujisawa K, Kono T, Ishibashi T (2008) TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 49:3151–3157. doi:10.1167/iovs.07-1249